FDA Approves Second Booster Dose

|Gray Area of the Law Blog

On Tuesday, March 28th, the US Food and Drug Administration approved a second booster dose of the Pfizer-BioNTech or Moderna Covid-19 vaccines out of a concern for a potential surge in cases due to the BA.2 variant. It is to be available to all adults 50 years or older as well as immunocompromised individuals, four months after their first booster.

Kimberly Bonvissuto writes a comprehensive article about it in the March 30th edition of McKnight Senior Living.

This article is for informational purposes only and does not provide legal advice. Please do not act or refrain from acting based on anything you read here. Please review the full disclaimer for more information. Relying on the information provided in this article or communicating with Lowndes through our website does not create an attorney/client relationship.

Related Expertise

Jump to Page

We use cookies on our website to improve functionality and collect statistical information on our website traffic. For details on how we use cookies, please see our Privacy Policy. By using this website, you agree to our Privacy Policy and Terms of Use

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. This type of cookie does not collect any personally identifiable information about you and does not track your browsing habits. You may disable necessary cookies by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies (also known as performance cookies) help us improve our website by collecting and reporting information on its usage at an aggregate level. You may disable analytical cookies by clicking on the Manage Cookies button.